Bisphosphonates

mechanisms of action

Anke J Roelofs, Mike Rogers

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Bisphosphonates are widely used in the treatment of diseases involving excessive bone resorption, including post-menopausal osteoporosis, Paget’s disease of bone, tumour-associated bone disease, and hypercalcaemia of malignancy. These drugs have a high affinity for bone mineral and predominantly target bone-resorbing osteoclasts in vivo. Since their discovery in the late 1960’s, bisphosphonates have been successfully used in the clinical setting for more than 3 decades. However, it is only in recent years that major advances have been made in our understanding of the cellular and molecular mechanisms of action of bisphosphonates. This chapter will cover the history of the development, chemistry, biological actions, and molecular mechanisms of action of bisphosphonates, as well as a discussion on anti-tumour activity, and adverse effects.
Original languageEnglish
Title of host publicationHandbook of Cancer-Related Bone Disease
EditorsR E Coleman, P A Abrahamsson, P Hadji
Place of PublicationBristol, United Kingdom
PublisherBioScientifica
Pages71-89
Number of pages19
ISBN (Print)1901978308, 978-1901978308
Publication statusPublished - Mar 2010

Fingerprint

Diphosphonates
Osteitis Deformans
Bone and Bones
Neoplasms
Postmenopausal Osteoporosis
Bone Diseases
Hypercalcemia
Osteoclasts
Bone Resorption
Minerals
History
Pharmaceutical Preparations

Cite this

Roelofs, A. J., & Rogers, M. (2010). Bisphosphonates: mechanisms of action. In R. E. Coleman, P. A. Abrahamsson, & P. Hadji (Eds.), Handbook of Cancer-Related Bone Disease (pp. 71-89). Bristol, United Kingdom: BioScientifica.

Bisphosphonates : mechanisms of action. / Roelofs, Anke J; Rogers, Mike.

Handbook of Cancer-Related Bone Disease. ed. / R E Coleman; P A Abrahamsson; P Hadji. Bristol, United Kingdom : BioScientifica, 2010. p. 71-89.

Research output: Chapter in Book/Report/Conference proceedingChapter

Roelofs, AJ & Rogers, M 2010, Bisphosphonates: mechanisms of action. in RE Coleman, PA Abrahamsson & P Hadji (eds), Handbook of Cancer-Related Bone Disease. BioScientifica, Bristol, United Kingdom, pp. 71-89.
Roelofs AJ, Rogers M. Bisphosphonates: mechanisms of action. In Coleman RE, Abrahamsson PA, Hadji P, editors, Handbook of Cancer-Related Bone Disease. Bristol, United Kingdom: BioScientifica. 2010. p. 71-89
Roelofs, Anke J ; Rogers, Mike. / Bisphosphonates : mechanisms of action. Handbook of Cancer-Related Bone Disease. editor / R E Coleman ; P A Abrahamsson ; P Hadji. Bristol, United Kingdom : BioScientifica, 2010. pp. 71-89
@inbook{7a6add46bdf44d1c8cf9fb02a14508fe,
title = "Bisphosphonates: mechanisms of action",
abstract = "Bisphosphonates are widely used in the treatment of diseases involving excessive bone resorption, including post-menopausal osteoporosis, Paget’s disease of bone, tumour-associated bone disease, and hypercalcaemia of malignancy. These drugs have a high affinity for bone mineral and predominantly target bone-resorbing osteoclasts in vivo. Since their discovery in the late 1960’s, bisphosphonates have been successfully used in the clinical setting for more than 3 decades. However, it is only in recent years that major advances have been made in our understanding of the cellular and molecular mechanisms of action of bisphosphonates. This chapter will cover the history of the development, chemistry, biological actions, and molecular mechanisms of action of bisphosphonates, as well as a discussion on anti-tumour activity, and adverse effects.",
author = "Roelofs, {Anke J} and Mike Rogers",
year = "2010",
month = "3",
language = "English",
isbn = "1901978308",
pages = "71--89",
editor = "Coleman, {R E} and { Abrahamsson}, {P A} and P Hadji",
booktitle = "Handbook of Cancer-Related Bone Disease",
publisher = "BioScientifica",

}

TY - CHAP

T1 - Bisphosphonates

T2 - mechanisms of action

AU - Roelofs, Anke J

AU - Rogers, Mike

PY - 2010/3

Y1 - 2010/3

N2 - Bisphosphonates are widely used in the treatment of diseases involving excessive bone resorption, including post-menopausal osteoporosis, Paget’s disease of bone, tumour-associated bone disease, and hypercalcaemia of malignancy. These drugs have a high affinity for bone mineral and predominantly target bone-resorbing osteoclasts in vivo. Since their discovery in the late 1960’s, bisphosphonates have been successfully used in the clinical setting for more than 3 decades. However, it is only in recent years that major advances have been made in our understanding of the cellular and molecular mechanisms of action of bisphosphonates. This chapter will cover the history of the development, chemistry, biological actions, and molecular mechanisms of action of bisphosphonates, as well as a discussion on anti-tumour activity, and adverse effects.

AB - Bisphosphonates are widely used in the treatment of diseases involving excessive bone resorption, including post-menopausal osteoporosis, Paget’s disease of bone, tumour-associated bone disease, and hypercalcaemia of malignancy. These drugs have a high affinity for bone mineral and predominantly target bone-resorbing osteoclasts in vivo. Since their discovery in the late 1960’s, bisphosphonates have been successfully used in the clinical setting for more than 3 decades. However, it is only in recent years that major advances have been made in our understanding of the cellular and molecular mechanisms of action of bisphosphonates. This chapter will cover the history of the development, chemistry, biological actions, and molecular mechanisms of action of bisphosphonates, as well as a discussion on anti-tumour activity, and adverse effects.

M3 - Chapter

SN - 1901978308

SN - 978-1901978308

SP - 71

EP - 89

BT - Handbook of Cancer-Related Bone Disease

A2 - Coleman, R E

A2 - Abrahamsson, P A

A2 - Hadji, P

PB - BioScientifica

CY - Bristol, United Kingdom

ER -